Singapore markets closed

BioAtla, Inc. (BCAB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.2500+0.0900 (+2.85%)
At close: 04:00PM EDT
3.2500 0.00 (0.00%)
After hours: 05:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 156.35M
Enterprise value 47.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.21
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.37

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3-3.07%
S&P500 52-week change 322.38%
52-week high 34.0680
52-week low 31.2400
50-day moving average 32.8071
200-day moving average 32.3031

Share statistics

Avg vol (3-month) 3624.1k
Avg vol (10-day) 31M
Shares outstanding 548.11M
Implied shares outstanding 648.11M
Float 833.1M
% held by insiders 19.67%
% held by institutions 164.66%
Shares short (15 Apr 2024) 45.42M
Short ratio (15 Apr 2024) 47.48
Short % of float (15 Apr 2024) 412.59%
Short % of shares outstanding (15 Apr 2024) 411.26%
Shares short (prior month 15 Mar 2024) 45.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-46.93%
Return on equity (ttm)-98.37%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -128.47M
Net income avi to common (ttm)-123.46M
Diluted EPS (ttm)-2.5800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)111.47M
Total cash per share (mrq)2.32
Total debt (mrq)2.46M
Total debt/equity (mrq)3.48%
Current ratio (mrq)4.11
Book value per share (mrq)1.47

Cash flow statement

Operating cash flow (ttm)-104.02M
Levered free cash flow (ttm)-61.29M